As of Aug 28
| -1.68 / -1.22%|
The 30 analysts offering 12-month price forecasts for Bayer have a median target of 160.85, with a high estimate of 182.30 and a low estimate of 124.54. The median estimate represents a +18.25% increase from the last price of 136.02.
The current consensus among 30 polled investment analysts is to Hold stock in Bayer. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.